Avenue Therapeutics News - ATXI

Company Name	Stock Ticker Symbol	Market	Type
Avenue Therapeutics Inc	ATXI	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.0026	-1.93%	0.132	18:49:58

Open Price	Low Price	High Price	Close Price	Prev Close
0.1346	0.125	0.1377	0.13	0.1346

more quote information »

Recent News

Date	Time	Source	Heading
3/25/2024	08:30	GLOBE	Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL)..
3/18/2024	16:05	GLOBE	Avenue Therapeutics Reports Full Year 2023 Financial Results..
3/15/2024	08:15	GLOBE	Avenue Therapeutics Receives Positive Listing Determination..
3/11/2024	08:00	GLOBE	Avenue Therapeutics to Present BAER-101 Preclinical Data at..
3/08/2024	16:31	EDGAR2	Form PRE 14C - Other preliminary information statements
3/08/2024	16:15	EDGAR2	Form 8-K - Current report
2/22/2024	08:30	GLOBE	Avenue Therapeutics Announces Publication in Drug..
2/02/2024	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
1/29/2024	08:00	EDGAR2	Form DEF 14C - Other definitive information statements
1/24/2024	16:11	EDGAR2	Form S-3 - Registration statement under Securities Act of..
1/17/2024	17:05	EDGAR2	Form PRE 14C - Other preliminary information statements
1/12/2024	06:01	EDGAR2	Form 8-K - Current report
1/11/2024	08:00	GLOBE	Avenue Therapeutics to Present at Sidoti January Micro-Cap..
1/08/2024	17:28	EDGAR2	Form 8-K - Current report
1/05/2024	09:15	GLOBE	Avenue Therapeutics Enters into Warrant Exercise..
1/04/2024	08:30	GLOBE	Avenue Therapeutics Reaches Final Agreement with the U.S...
1/02/2024	08:30	GLOBE	Avenue Therapeutics Announces Completion of Enrollment in..
12/13/2023	16:03	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
12/13/2023	16:02	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/01/2023	08:30	GLOBE	Avenue Therapeutics to Present at American Epilepsy Society..
11/28/2023	16:05	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
11/28/2023	16:01	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
11/24/2023	13:19	EDGAR2	Form 8-K - Current report
11/13/2023	16:15	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/2023	16:10	EDGAR2	Form 8-K - Current report
11/13/2023	16:05	GLOBE	Avenue Therapeutics Reports Third Quarter 2023 Financial..
11/02/2023	16:10	EDGAR2	Form 8-K - Current report
11/02/2023	15:00	GLOBE	Avenue Therapeutics Announces Closing of $5.0 Million Public..
11/02/2023	09:00	EDGAR2	Form 424B4 - Prospectus [Rule 424(b)(4)]
10/31/2023	09:15	GLOBE	Avenue Therapeutics Announces Pricing of $5.0 Million Public..
10/05/2023	17:05	EDGAR2	Form FWP - Filing under Securities Act Rules 163/433 of free..
9/29/2023	17:23	EDGAR2	Form S-1/A - General form for registration of securities..
9/28/2023	16:25	EDGAR2	Form 8-K - Current report
9/27/2023	16:03	EDGAR2	Form 8-K - Current report
9/18/2023	17:18	EDGAR2	Form S-1 - General form for registration of securities under..
9/08/2023	16:15	EDGAR2	Form 8-K - Current report
9/05/2023	08:30	GLOBE	Avenue Therapeutics to Present at H.C. Wainwright 25th..
8/14/2023	16:01	GLOBE	Fortress Biotech Reports Second Quarter 2023 Financial..
8/11/2023	16:25	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/2023	16:20	EDGAR2	Form 8-K - Current report
8/10/2023	16:15	GLOBE	Avenue Therapeutics Reports Second Quarter 2023 Financial..
8/01/2023	08:30	GLOBE	Avenue Therapeutics Announces High Potency and Full Efficacy..
7/27/2023	08:30	GLOBE	Avenue Therapeutics Announces First Patient Dosed in Phase..
7/25/2023	08:30	GLOBE	Avenue Therapeutics Announces Agreement with the FDA on the..
7/21/2023	16:37	EDGAR2	Form 8-K - Current report
7/05/2023	16:10	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/05/2023	16:09	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/05/2023	16:07	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/03/2023	13:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
6/28/2023	16:56	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]